Milga

Indications:

Diseasos of various °rifting that affect partirtularly  peripheral_ neural system, neuritis, neuralgia, polyneuropathies (e.g. diabetic, alcoholic, etc.), myalgia, radicular syndromes, retrobulbar neuritis, herpes zoster, facial palsy and trigeminal neuralgia.

Dosage &Administration:

I Milga tablet up to 3 times daily. The tablet should be taken with adequate amount of liquid.

Sileasfilasisrmi

in rare in tvi ua cases t ere may e allergic hypersensitivity cactions.

Contraindications:

hypersensitivity towards any of the ingredients is suspected, otherwise there are no known contraindications.

Precautions and Warnings:

pecial precautions are required but doses of pyridoxine li^.jier than 200mg over a long 

 period of time should be avoided.

Drug -Drug interactions 

here are interactions with INK D-penicillamine, cycloserine^­theophylline & MAOls. Therapeutic doses of vitamin B6 may reduce the effectiveness of L-dopa & hydralazine.

Manufactured by
EVA Pharma for Pharmaceuticals &
Medical Appliances, Egypt